跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Bilaxten
Approved
STANDARD
Bilaxten
A. Menarini Manufacturing Logistics and Services S.R.L.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
eccdc59dafc74644
Company
A. Menarini Manufacturing Logistics and Services S.R.L.
Type
Standard
Approval Details
Approval Id
eccdc59dafc74644
Drug Approval Philippines Name
Bilaxten
Product Name
Bilaxten
Registration Number
DR-XY43523
Brand Name
Bilaxten
Generic Name
Bilastine
Dosage Form
Tablet
Dosage Strength
20mg
Manufacturer
A. Menarini Manufacturing Logistics and Services S.R.L.
Trader
A. Menarini Asia-Pacific Holdings Pte. Ltd.
Importer
A. Menarini Philippines, Inc.
Issuance Date
24 June 2024
Expiry Date
07 July 2029
Pharmacologic Category
Antihistamine
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
eccdc59dafc74644
Type
Standard
Back to Philippines FDA Approvals
Bilaxten - Philippines FDA Drug Approval Details